Pilot Study of Laparoscopic Gastric Plication in Adolescents With Severe Obesity

Sponsor
Virginia Commonwealth University (Other)
Overall Status
Completed
CT.gov ID
NCT01980758
Collaborator
Children's Hospital of Richmond (Other)
4
1
1
58.2
0.1

Study Details

Study Description

Brief Summary

The proposed study aims to investigate the effects of laparoscopic gastric plication (LGP) on excess body weight, body mass index, and weight-related medical and psychological co-morbidities in obese adolescents. Additionally, we will evaluate the safety and efficacy of this procedure (implemented within a multidisciplinary comprehensive lifestyle modification program) on changes in the patients' medical status, psychosocial and psychological functioning, physical fitness, and health-related quality of life.

Study hypothesis:
  1. Laparoscopic gastric plication performed on carefully selected obese adolescents within a multidisciplinary treatment program providing pre and post-surgical behavioral and psychological support and education will result in: a) initial and sustained reductions in excess body weight and body mass index, b) improvements in psychological functioning, physical fitness, and health-related quality of life, and c) reduction in weight-related comorbidities.

  2. LGP will be a safe procedure, with complication rates that are comparable to or lower than what has been found in other published reports of surgical weight loss procedures used in obese adolescents.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Laparoscopic Gastric Plication
N/A

Detailed Description

The complete study protocol, which is described in detail below, spans 3 years and includes 11 research assessment points (Pre-1, Pre-2, T0, T1, T2, T3, T4, T5, T6, T7, and T8). Please refer to Figure 2. Study Protocol from Enrollment to Post-Surgical Assessments. Select pre-treatment assessments will be conducted initially (Pre-1), followed by a 2-month pre-surgical education and lifestyle modification treatment program, consisting of four visits with psychology, nutrition, exercise, and surgery. After successful completion of this pre-surgical education program, a more comprehensive pre-surgical assessment by a surgeon (Pre-2) will be conducted. If patients decide to pursue the study, in the two weeks prior to surgery, participants will be asked to adhere to a pre-surgical diet, exclusion and inclusion criteria will be reviewed again by the study team, and verbal consent/assent will be re-confirmed with adolescents and parent(s). Following surgery (T0), comprehensive follow-up care will be provided via the multidisciplinary team at the Healthy Lifestyles Center (HLC) at Children's Hospital of Richmond at Virginia Commonwealth University (CHoR at VCU). The follow-up period will be divided into three phases: 1) Early Post-Operative Phase (0-5 months), 2) Late Post-Operative phase (6-12 months), and 3) Long-term Follow-up Phase (13-36 months). In conjunction with clinical follow-up, repeat standardized research assessments will be conducted post-operatively at 1-2 weeks (T1), 6 weeks (T2), 3 months (T3), 6 months (T4), 12 months (T5), 18 months (T6), 24 months (T7), and 36 months (T8). Specific screening, pre-surgical, perioperative, and post-surgical study procedures at each time point are described fully below and outlined in Figure 2 and Table 1. Additionally, all research measures are described in detail in the Measures Section. If any participant requires any additional visit during the time of this study, data from these visits will also be collected for this study. Care directly related to the surgery and study will not be billed but other medical issues such as hypertension, diabetes, hypercholesterolemia and depression may require management outside of the scope of the study and will be billed accordingly

Study Design

Study Type:
Interventional
Actual Enrollment :
4 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Pilot Study of Laparoscopic Gastric Plication in Adolescents With Severe Obesity
Study Start Date :
May 1, 2013
Actual Primary Completion Date :
Mar 8, 2018
Actual Study Completion Date :
Mar 8, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Surgery

Laparoscopic Gastric Plication

Procedure: Laparoscopic Gastric Plication
The study will examine the effects of a type of weight loss surgery on obese adolescents age 14-19. ) The study protocol includes pre-treatment assessments followed by a 2-month education and lifestyle modification treatment program. Following surgery, comprehensive follow-up care will be provided over a 3 year period.

Outcome Measures

Primary Outcome Measures

  1. Reduction of Excess Body Weight [6 months post-surgery]

Secondary Outcome Measures

  1. Reduction in comorbidities to obesity [6 months]

  2. Changes in lifestyle choices [1 year]

  3. Improvement in quality of life [3 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years to 19 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 14 - 19.

  • At physical maturity.

  • BMI of greater than or equal to 35 kg/m2 with major comorbidities, or BMI of greater than 40 kg/m2 with other weight related comorbidities.

  • Must have undergone comprehensive pre-surgical assessments by a multi-disciplinary team.

  • Must have at least 6 months of medically observed and attempted non-surgical weight loss.

  • Must have demonstrated suboptimal weight loss following participation in a lifestyle intervention.

  • Must have parents involved in all phases of recruitment and intervention.

Exclusion Criteria:
  • Underlying genetic or endocrine disorder, which would preclude weight loss through behavioral and surgical techniques.

  • Less than six months of participation in a medically-supervised weight management efforts.

  • Active untreated, unstable psychopathology (to include active psychosis, severe depression, or significant eating pathology), as determined by psychological evaluation.

  • Active suicidal ideation, as determined by psychological evaluation.

  • Inadequate social support, as determined by psychological evaluation.

  • Inability to provide informed consent/assent, as evidenced by clinical interview and cognitive assessments.

  • Severe mental retardation, as evidenced by clinical interview and cognitive assessments.

  • Demonstrated pattern of poor adherence to medical regimen and lifestyle modification.

  • Active substance abuse, including tobacco use, as demonstrated by clinical interview and psychological evaluation. Inadequate knowledge of risks and patient responsibilities, as determined by clinical interview and knowledge quiz.

  • Reported pregnancy within the past year, current pregnancy, or planning to become pregnant in the next three years.

  • History or clinical symptoms of severe gastrointestinal reflux disease (GERD)

  • Person is not deemed for medical reasons to be a surgical candidate.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Children's Hospital of Richmond at VCU Richmond Virginia United States 23298

Sponsors and Collaborators

  • Virginia Commonwealth University
  • Children's Hospital of Richmond

Investigators

  • Principal Investigator: David Lanning, MD, PhD, Virginia Commonwealth University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Virginia Commonwealth University
ClinicalTrials.gov Identifier:
NCT01980758
Other Study ID Numbers:
  • HM14809
First Posted:
Nov 11, 2013
Last Update Posted:
Jul 10, 2018
Last Verified:
Jul 1, 2018
Keywords provided by Virginia Commonwealth University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 10, 2018